<DOC>
	<DOCNO>NCT01231854</DOCNO>
	<brief_summary>The purpose study investigate comparative efficacy , safety efficiency ciclosporin microemulsion alitretinoin adult severe atopic hand dermatitis .</brief_summary>
	<brief_title>Ciclosporin Versus Alitretinoin Severe Atopic Hand Dermatitis .</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Alitretinoin</mesh_term>
	<criteria>Male female Patients age &gt; 18 year ≤ 75 year Body weight 50 100 kg Chronic hand dermatitis ( duration &gt; 6 month ) Atopic constitution accord Erlanger Atopiescore1 and/or positive personal history atopic eczema , allergic rhinitis , allergic asthma and/or elevate serum IgE Severe hand dermatitis respond treatment potent topical steroid least 4 week within past 6 month due IGA Written inform consent Participation clinical trial within past 4 week Pregnancy/breastfeeding Women within reproductive age except woman fulfil least one follow criterion throughout total study least 5 week active study treatment case early study termination : postmenopausal woman ( 12 month physiological amenorrhoea 6 month amenorrhoea serum FSH level &gt; 40 mlU/ml ) , postoperative ( 6 week bilateral ovariectomy without hysterectomy ) Regular proper use least two method contraception , include least one method contraception failure rate &lt; 1 % per year ( eg , implant , depot preparation , oral contraceptive , IUD ) . vasectomy partner . Women within reproductive age , meet follow criterion throughout whole study case early study termination 5 week active therapy : The patient understand teratogenic risk associate take study medication . The patient understand need strict monthly monitoring , need reliable , continuous contraception need regular pregnancy test throughout study case early study termination 5 week active therapy . The patient able adequately reliably apply method contraception . The patient inform possible consequence pregnancy know must immediately contact physician case suspect pregnancy . The patient give informed consent know potential risk necessary measure avoid pregnancy . Blood and/or plasma donation whole study period . In case early study termination blood plasma donation allow 1 month end active study treatment UVtherapy within past 3 month Concurrent photoand / photochemotherapy Known Hypersensitivity / Intolerance ciclosporin , alitretinoin ingredient Immunosporin® Toctino® Known Allergy peanuts soya Known Hereditary fructose intolerance Acute and/or uncontrolled chronic infectious disease Known Congenital acquire immune deficiency Malignant tumor ( past present ) Uncontrolled arterial hypertension ( RR systolic ≥ 160 mm Hg and/or RR diastolic≥ 90 mm Hg despite antihypertensive treatment ) Renal insufficiency ( Serum creatinine normal range ) Liver insufficiency ( CHILD ≥ Stadium B ) Not sufficiently control hyperlipidemia ( LDL/HDL ratio &gt; 4 despite medical treatment ) Clinically significant thyroid hypofunction Known Hypervitaminosis A Concurrent supplementation vitamin A treatment retinoids Concurrent tetracycline therapy Concurrent therapy St. John 's wort ( `` Johanniskraut '' ) Known genetic disease cause increase UV light sensitivity Xeroderma pigmentosum , Cockaynesyndrome , Bloom syndrome Known Drug and/or alcohol abuse Known significant psychiatric morbidity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>atopic hand dermatitis</keyword>
	<keyword>Chronic hand dermatitis</keyword>
</DOC>